Document Detail

Fade of pulmonary function during residual neuromuscular blockade.
MedLine Citation:
PMID:  15888849     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: A decrement in evoked muscle force with repetitive nerve stimulation (fade) suggests impaired neuromuscular transmission. We tested the hypothesis that fade of pulmonary function, ie, a decrease in values of FVC with the second spirometric maneuver compared to the first maneuver, occurs during impaired neuromuscular transmission. DESIGN: Prospective study. PARTICIPANTS: Six healthy male volunteers. INTERVENTIONS: A series of three consecutive spirometric maneuvers was performed every 5 min in six awake healthy volunteers before, during, and after partial paralysis evoked by rocuronium (0.01 mg/kg IV plus 2 to 8 microg/kg/min). MEASUREMENTS AND RESULTS: We measured FVC, FEV(1), forced inspiratory volume in 1 s (FIV(1)), peak expiratory flow (PEF), and peak inspiratory flow (PIF) by spirometry, and force of adductor pollicis muscle by mechanomyography (train-of-four [TOF] stimulation). A statistically significant fade (reduction of the second maneuver from the first maneuver) of FVC, FEV(1), FIV(1), PEF, and PIF was observed during neuromuscular blockade. With peak relaxation (TOF ratio, 0.5) fade amounted to medians of 10% (interquartile range [IQR], 9 to 23%), 7% (IQR, 2 to 16%), 31 (IQR, 19 to 47%), 9% (IQR, 3 to 24%), and 30% (IQR, 5 to 43%), respectively. A fade of >or= 10% was always associated with a clinically relevant (>or= 10%) FVC reduction from baseline (ie, FVC before rocuronium administration). However, FVC reduction from baseline was still present in 23% of measurements without a relevant FVC fade. CONCLUSIONS: A clinically relevant fall (fade) in FVC from the first to the second value during or after neuromuscular blockade suggests impaired pulmonary function and may be due to muscle paralysis. For this reason, the first (best) FVC value may overestimate pulmonary function and expose the patient to an unidentified risk.
Matthias Eikermann; Harald Groeben; Barbara Bünten; Jürgen Peters
Related Documents :
18317379 - Sex differences in pulmonary function during exercise.
11901909 - Functional evaluation before lung resection.
16728229 - Determinants of exercise function following univentricular versus biventricular repair ...
3665399 - The transfer factor (diffusing capacity) as a predictor of hypoxaemia during exercise i...
20671059 - Right ventricular load at exercise is a cause of persistent exercise limitation in pati...
6807559 - Limitations to exercise capacity and endurance: pulmonary system.
20093659 - Effect of recovery duration from prior exhaustive exercise on the parameters of the pow...
8149449 - Exercise and the immune response.
692309 - Football fatalities in actuarial perspective.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Chest     Volume:  127     ISSN:  0012-3692     ISO Abbreviation:  Chest     Publication Date:  2005 May 
Date Detail:
Created Date:  2005-05-12     Completed Date:  2005-06-10     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0231335     Medline TA:  Chest     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1703-9     Citation Subset:  AIM; IM    
Klinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Essen, Hufelandstr. 55, D-45122 Essen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Androstanols / pharmacology*
Myasthenia Gravis / physiopathology*
Neuromuscular Nondepolarizing Agents / pharmacology*
Prospective Studies
Respiratory Mechanics / drug effects*
Vital Capacity
Reg. No./Substance:
0/Androstanols; 0/Neuromuscular Nondepolarizing Agents; 143558-00-3/rocuronium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Alveolar nitric oxide and effect of deep inspiration during methacholine challenge.
Next Document:  Chronic idiopathic cough: a discrete clinical entity?